Document is current
Any future updates will be listed below
-
Authors
Certo, Michelangelo https://orcid.org/0000-0002-5568-3465
Pontarini, Elena
Gilbert, Sebastian G. https://orcid.org/0000-0002-7502-8409
Schmidt, Ronny https://orcid.org/0009-0002-5173-8649
Turner, Jason D. https://orcid.org/0000-0002-5423-5302
Lucchesi, Davide https://orcid.org/0000-0002-8019-556X
Apostolo, Daria
Cavallaro, Giulia
Smith, Charlotte G.
Colafrancesco, Serena
Campos, Joana
Nayar, Saba
Schröder, Christoph
Fisher, Benjamin A. https://orcid.org/0000-0003-4631-549X
Spill, Fabian https://orcid.org/0000-0001-8462-5080
Bombardieri, Michele https://orcid.org/0000-0002-3878-5216
Mauro, Claudio https://orcid.org/0000-0002-3736-0099
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 10 June 2025
First Online: 4 August 2025
Competing interests
: C.M. is a founder and CSO of Solute Guard Therapeutics (SGTx). M.B. is a member of the scientific advisory board of SGTx. The other authors declare no competing interests.
